Key result
A step-by-step PCR-based protocol was developed to adapt and quantify RBM20-dependent exon-expression of human target genes using induced pluripotent stem cell-derived cardiomyocytes.
Why the study?
Mutations in splice factors such as RNA-binding motif 20 (RBM20) are linked to cardiac diseases, prompting the need to transfer RBM20-dependent splicing methods from rat to human.
This protocol enables the quantification of RBM20-dependent exon splicing in human iPSC-derived cardiomyocytes, facilitating research into splice factor mutations linked to cardiac diseases.
Answers are grounded in this paper and cite their sources.
Provides transferable PCR assay for human RBM20 splicing in iPSC-CMs; extends rodent models but leaves clinical translation open.
Gene splicing is a fine-tuned process orchestrated by splice factors including RNA-binding motif 20 (RBM20), and their mutations are linked to the development of cardiac diseases. Here, we provide a step-by-step protocol to transfer RBM20-dependent splicing from rat to human. This protocol describes a PCR-based approach to adapt and quantify RBM20-dependent exon-expression of human target genes. We detail the primer design, the use of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) for RNA isolation, followed by quantification of splicing products. For complete details on the use and execution of this profile, please refer to Streckfuss-Bömeke et al. (2017).
No takes yet. Share an insight, caveat, or question.
Rebs et al. (2022) studied Cardiac diseases. Quantitative RT-PCR protocol for RBM20-dependent exon splicing was evaluated. A step-by-step PCR-based protocol was developed to adapt and quantify RBM20-dependent exon-expression of human target genes using induced pluripotent stem cell-derived cardiomyocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: